Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Hepatol Res ; 36(2): 78-85, 2006 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16908213

RESUMO

Gallium-67 ((67)Ga) has been used as a tumor or inflammation-imaging agent in nuclear medicine, although underlying mechanism has not been fully elucidated. To gain some insights into the mechanism of (67)Ga uptake by injured liver, we analyzed the difference between perivenous and periportal regions of rat liver in terms of (67)Ga uptake by hepatocytes at the site of inflammation caused by carbon tetrachloride (CCl(4))-treatment. Distribution of (67)Ga in rat liver sections was monitored with a BAS5000 system following hepatic injury by CCl(4)-treatment. Periportal hepatocytes (PPH) and perivenous hepatocytes (PVH) were prepared by modified digitonin-collagenase perfusion technique. Uptakes of (67)Ga in PVH region and PPH region reached to a maximum 2 days after CCl(4)-treatment, and the amount of maximum uptake of (67)Ga in PVH was twice as much as that in PPH. Liver damage as measured by lipid peroxidation and (45)Ca uptake occurred in PVH region within 1 day after CCl(4)-treatment. Incorporation of bromodeoxyuridine into hepatocytes reached to a maximum 2 days after CCl(4)-treatment, and peaked amount of DNA synthesis in PVH was twice as much as that in PPH. These results indicated that the uptake of (67)Ga by the PVH region was carried out during hepatic regeneration phase rather than hepatic damage period by CCl(4)-treatment.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...